Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px
Document › Details

Euronext N.V.. (2/19/18). "Press Release: Euronext Publishes Full Year 2017 Results". Amsterdam, Brussels, et al..

Product Product finance
Person Person Boujnah, Stéphane (Euronext 201711 CEO)
     


STRONG SET OF FINANCIALS THANKS TO STRENGTHENED POSITION ON KEY MARKETS AND FOCUSED ACQUISITIONS


Today Euronext, the leading pan-European exchange in the Eurozone with nearly 1,300 listed issuers, announces its results for the full year 2017.


Strong operating performance for the full year 2017

> Increase in revenue to €532.3 million (+7.2%[1]):
>> Despite low volatility, cash trading revenues at €190.3m up 5.3% , thanks to strong market share at 64.4% (67.1% in Q4) and improving volumes (ADV at €7.5bn up 6.7%). Strong growth in listing revenue
>> Solid contribution from revenue diversification initiatives with FastMatch and Agility for Growth contributing respectively to the group’s revenue for €7.2m and €9.8m

> Robust EBITDA, at €297.8m (+4.9%), with margin at 55.9% (-1.2pt), despite the costs of ramp-up of projects
>> Continued core business cost discipline partially offsetting the impact of the change of perimeter, MIFID II compliance and Optiq® projects, and slowing the growth of operational expenses (€234.5 million, up 10.3%)
>> €10.9 million of cumulated gross efficiencies achieved since Q2 2016, as part of the cost reduction programme announced in the Agility for Growth plan

> Significant increase in EPS (basic): €3.47 (+22.4%). Adjusted EPS at €3.09[2] (+4.8%)
>> Net income, share of the Group, at €241.3m up 22.5%: combination of good operating performance, capital gain from LCH SA share swap[3] (€40.6m) and non-recurring tax release in Q4 (€20.4m)

> First components of Optiq® (cash and derivatives market data gateway) live in 2017, and confirmed delivery of the cash trading platform in H1 2018


Proactive and disciplined capital deployment strategy

> Over €300m of capital invested or committed into 8 companies over the last 13 months

> Proposed dividend of €121m (€1.73 per share, +21.8%), representing 50% of 2017 reported net income, including LCH SA share swap capital gain, to the AGM on 15 May 2018


Outlook for 2018 and 2019

> Confirmed 2019 target of an EBITDA margin of 61% to 63% excluding clearing, with core business revenue growth at +2.0% CAGR 2015-2019 and cost gross savings of €22m

> Core business costs reduction expected to start in H2 2018, after the delivery of IT projects

> Agility for Growth initiatives expected to contribute to €55m revenue (vs. €70m in May 2016) at 50% EBITDA margin in 2019, due to re-allocation of resources on most value creating growth projects

> 2019 financials will also benefit from the full-year contribution of FastMatch and of the Irish Stock Exchange (after closing)


Key figures - in €m, unless stated otherwise

2017
2016
% change

Revenue
532.3
496.4
+7.2%

Operational expenses excluding D&A
-234.5
-212.5
+10.3%

EBITDA
297.8
283.9
+4.9%

EBITDA margin
55.9%
57.2%
-1.2pt

Net income, share of the Group
241.3
197.0
+22.5%

EPS (adjusted)2
3.09
2.95
+4.8%

DPS
1.73
1.42
+21.8%


Stéphane Boujnah, Chief Executive Officer and Chairman of the Managing Board of Euronext, said:

“2017 was a strong year with key milestones reached for Euronext. We launched growth initiatives, resolved the uncertainties related to clearing, secured the first significant acquisitions since our IPO, delivered the first components of Optiq® and became MIFID II compliant. As a consequence, we are publishing today a strong set of results, showing the strength and growth profile of a profoundly transformed Euronext.

Our confidence is strong for the next two years. Core business revenue should grow in line with forecasts, and we will continue our cost control discipline to ensure the 61% to 63% EBITDA margin target is reached in 2019, excluding clearing activities. FastMatch and the Irish Stock Exchange at closing will further contribute to our 2019 performance. To reflect our active management of priorities, we now forecast €55m revenue at a 50% EBITDA margin for Agility for Growth initiatives in 2019. We will continue to deploy our capital through pertinent acquisitions and keep a 50% dividend pay-out ratio, showing our continued commitment to provide value creation to our shareholders.”

Please download the document attached to read the full press release [ https://www.euronext.com/sites/www.euronext.com/files/euronext_fy_2017_results_press_release_0.pdf ]


[1] Unless stated otherwise, percentages compare 2017 data to 2016 data
[2] Definition in appendix
[3] Swap without cash settlement. Please refer to “Highlights of the period” paragraph


About Euronext

Euronext is the leading pan-European exchange in the Eurozone with nearly 1,300 listed issuers worth close to €3.6 trillion in market capitalisation as of end December 2017, an unmatched blue chip franchise consisting of 24 issuers in the Morningstar® Eurozone 50 Index? and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets. Its total product offering includes Equities, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, Euronext also operates Euronext GrowthTM (formerly known as Alternext) and Euronext AccessTM (formerly known as the Free Market). For the latest news, find us on Twitter (www.twitter.com/euronext) and LinkedIn (www.linkedin.com/company/euronext).


Disclaimer

This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

   
Record changed: 2018-03-02

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

More documents for Euronext (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px




» top